BMBS COST Action B35
Lipid Peroxidation Associated Disorders: LPO
Descriptions are provided by the Actions directly via e-COST.
The main objective of the Action is to improve understanding, monitoring and control of lipid peroxidation in medicine and related biosciences and technologies. Secondary objectives - improve methods for detection and quantitation of lipid peroxidation for use in research and subsequent application (through biotechnology) to clinical science; - determine the prevalence of lipid peroxidation products in various inflammatory diseases and its correlation to disease severity or outcome; - elucidate the metabolism of important lipid peroxidation products and improve our understanding of their proinflammatory and other biological effects; - develop and test novel antioxidants that could have future applications in therapy for inflammatory diseases.
Biomedicine and Molecular Biosciences COST Action B35
- Description
- Parties
- Management Committee
General Information*
Chair of the Action:
Prof. Neven ZARKOVIC (HR)
Vice Chair of the Action:
Prof Tilman GRUNE (DE)
DC Rapporteurs:
Science officer of the Action:
Administrative officer of the Action:
Downloads*
Action Fact Sheet
Websites*
* content provided by e-COST.
Data is synchronised once per night.
